Impact of 13-valent pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease (IPD) among children <5 years old in the U.S.

Moore M, Taylor T, Pondo T, Barnes M, Petit S, Holtzman C, Lynfield R, Schaffner W, Harrison L, Zansky S, Reingold A, Farley MM, Scherzinger K, Thomas A, Zell E, McGee L, Beall B, Whitney C. Impact of 13-valent pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease (IPD) among children <5 years old in the U.S. Presented at: 9th International Symposium on Pneumococci and Pneumococcal Diseases; 2014 Mar 9-13; Hyderabad, India. Abstract. ISPPD-0467.